Reviewing So-Young International (NASDAQ:SY) & Zicix (OTCMKTS:ZICXD)

So-Young International (NASDAQ:SY) and Zicix (OTCMKTS:ZICXD) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for So-Young International and Zicix, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
So-Young International	1	0	1	0	2.00
Zicix	0	0	0	0	0.00

So-Young International currently has a consensus price target of $5.50, indicating a potential upside of 67.68%. Given So-Young International’s stronger consensus rating and higher probable upside, research analysts clearly believe So-Young International is more favorable than Zicix.

Institutional & Insider Ownership

35.3% of So-Young International shares are owned by institutional investors. 16.7% of So-Young International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility & Risk

So-Young International has a beta of 1.98, meaning that its share price is 98% more volatile than the S&P 500. Comparatively, Zicix has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500.

Earnings & Valuation

This table compares So-Young International and Zicix”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
So-Young International	$200.94 million	1.65	-$80.76 million	($0.99)	-3.31
Zicix	N/A	N/A	N/A	($100.14)	-0.03

Zicix has lower revenue, but higher earnings than So-Young International. So-Young International is trading at a lower price-to-earnings ratio than Zicix, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares So-Young International and Zicix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
So-Young International	-51.26%	-10.07%	-7.08%
Zicix	N/A	N/A	N/A

Summary

So-Young International beats Zicix on 8 of the 12 factors compared between the two stocks.

About So-Young International

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com. It provides content in various media formats on its online platform generated by users, including professional generated, content from in-house editorial team that shares opinions on specific new medical procedures and trends; user generated content comprising Beauty Diaries that provides details about medical institution, doctor, price, and other information on the treatment; professional user generated, contents from the medical aesthetic influencers; and doctor generated, content from doctors to generate knowledge. In addition, the company offers consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and software as a service. Further, it engages in research and development, production, sales, and agency of laser and other optoelectronic medical beauty equipment; manufacture and sells light therapy device, surgical laser device and other equipment; internet information and technology advisory; online medical treatment and consultation; management consulting; internet culture; micro finance services, as well as sells cosmetics products. The company was founded in 2013 and is headquartered in Beijing, China.

About Zicix

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas.